Phathom Pharmaceuticals
Paul Kowalczyk is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical and medical device industries. Currently serving as the Director of Regulatory Advertising & Promotion at Phathom Pharmaceuticals, Paul has held key leadership roles including Associate Director of Regulatory Affairs Advertising and Promotion at LEO Pharma Inc. US, Director of Regulatory Affairs for Promotional Review at Novo Nordisk, and Director of RA/QA at Nexcore Technology Inc. Notably, Paul also contributed to the field as the Corporate Staff VP of Regulatory Affairs Operations & Promotion at C.R. Bard, Inc., showcasing a strong background in regulatory compliance and promotional strategies throughout a successful career.
This person is not in any teams
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid.